Classes of medications used in type 2 diabetes
| Oral agents | Injectable agents |
|---|---|
| Biguanides | Short and rapid-acting human and animal insulins |
| Thiazolidinediones (‘glitazones’) | Short and rapid-acting insulin analogues |
| Dual PPAR agonists | Medium and long-acting human and animal insulins |
| Sulfonylureas | Medium and long-acting insulin analogues |
| Meglitinides (‘glinides’) | Mixed insulins |
| DPP-4 inhibitors (‘gliptins’) | GLP-1 agonists |
| Alpha-glucosidase inhibitors | Combined GLP-1 agonists and insulin |
| Amylin analogues | Inhaled agents |
| SGLT 2 inhibitors (‘gliflozins’) | Inhaled insulins |
| Combination oral preparations |
DPP4, dipeptidyl peptidase 4; GLP-1, glucagon-like peptide 1; PPAR, peroxisome proliferator-activated receptor; SGLT-2, sodium-glucose co-transporter 2.